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Viral infection in the kidney is characterized by tubular injury
induced directly by the virus and/or by cytotoxic
lymphocytes. Previously, we found that human tubular
epithelial cells express Toll-like receptor 3 (TLR3), melanoma
differentiation–associated gene 5 (MDA5), and retinoic
acid–inducible gene-I (RIG-I), all sensors of double-stranded
RNA (dsRNA) and potent inducers of antiviral activity. Here,
we demonstrate increased expression of these three dsRNA
sensors in kidney transplant biopsies during cytomegalovirus
or BK virus infection. In primary tubular epithelial cells,
dsRNA sensor activation induced the production of
pro-inflammatory TNF-a and antiviral IFN-b. Notably, dsRNA
also enhanced the expression of pro-apoptotic proteins;
however, dsRNA alone did not cause cell death due to the
expression of anti-apoptotic proteins. The dsRNA sensitized
tubular epithelial cells to apoptosis induced by an agonistic
antibody against the Fas receptor (CD95), an apoptotic
pathway that eliminates infected cells. These findings
indicate that tubular epithelial cells require at least two
signals to undergo apoptosis, which can help preserve
tubular integrity even under inflammatory conditions. Thus,
sensors of viral dsRNA promote antiviral, pro-inflammatory,
and pro-apoptotic responses in tubular epithelial cells, which
may orchestrate the control of viral infection in the kidney.
Kidney International (2012) 82, 664–675; doi:10.1038/ki.2012.206;
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Viral infection is a well-known complication after kidney
transplantation, which can lead to graft dysfunction and may
cause considerable morbidity and even mortality.1 Cytomeg-
alovirus (CMV), Epstein–Barr virus (EBV), and BK virus
(BKV) are latently present in the majority of the adult
population.2–4 In immunocompromised patients, these
viruses take the opportunity to reactivate. Moreover, they
may be transferred with the donor transplant, generally
resulting in a primary infection in recipients who lack
immunity against the virus. Infection can elicit severe
immune pathology leading to tubulointerstitial nephritis,
which is characterized by infiltrating lymphocytes.1,5,6 In
addition, some viruses, such as BKV, have a lytic replication
cycle inside renal tubular epithelial cells (TECs).7
Immune and non-immune cells can sense the presence of
viruses with receptors that recognize virus-associated mole-
cular patterns including nucleic acid structures.8 Upon ligand
binding, these pattern recognition receptors activate signaling
pathways that inhibit viral replication and activate antiviral
immune responses. A potent inducer of antiviral defense
mechanisms is double-stranded RNA (dsRNA), which
represents the genome of some viruses but is also an
intermediate formed by most viruses during their replication
cycle. Receptors that sense dsRNA are Toll-like receptor 3
(TLR3), which resides in the endosomal compartment and
thus recognizes dsRNA taken up from the environment, and
the cytoplasmic receptors melanoma differentiation–asso-
ciated gene 5 (MDA5) and retinoic acid–inducible gene-I
(RIG-I), which monitor viral replication within the cell.9
Upon ligand binding, dsRNA receptors activate nuclear
factor-kB (NF-kB), leading to the production of pro-
inflammatory cytokines and interferon-regulating factors 3/7
(IRF3/7), which promote transcription of type I interferons
(IFNs).10 Type I IFNs consecutively induce IFN-stimulated
genes, which regulate among others RNA stability and
protein synthesis, transport, and turnover, thereby inhibiting
viral replication.11,12 Viruses have developed various
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mechanisms to evade the human immune system, including
the suppression of type I IFN responses and transcription,
processing, and translation of host genes.8
If these cellular responses are not sufficient to control the
virus, the only way to block viral replication is death of the
infected cell. Recent studies indicate that dsRNA receptor
signaling can promote cell death by inducing the expression
and/or activation of various pro-apoptotic mediators.13–18
Programmed cell death, also called apoptosis, can be induced
in different ways during viral infection.19 Triggering of PPRs,
such as the dsRNA sensors mentioned above, can directly
promote apoptosis in the infected cells. On the other hand,
specialized cells of the immune system such as natural killer
cells and cytotoxic T lymphocytes selectively eliminate virus-
infected cells via two apoptotic pathways: the granule-
exocytosis pathway, in which granzymes have a key role,
and the death receptor–mediated pathway.20,21 Activation of
death receptors, such as CD95 (Fas), by their ligands, which
are highly expressed on activated cytotoxic lymphocytes, is
followed by assembly of the death-inducing signaling
complex and cleavage of pro-caspase 8, resulting in the
activation of effector caspases and nucleases.22 This death
receptor–induced cascade is known as the extrinsic pathway
of apoptosis. In addition, apoptosis can be induced by
various cellular stress signals that activate the mitochondrial
or intrinsic pathway. The intrinsic apoptotic pathway is
characterized by a disrupted balance between anti-apoptotic
Bcl-2-like proteins and pro-apoptotic BH3-only proteins,
leading to mitochondrial membrane permeabilization and
formation of the apoptosome, a protein complex that
activates effector caspases.23 The extrinsic and intrinsic
pathways are linked via the Bcl-2-interacting domain (BID),
which promotes mitochondrial disintegration once it is
cleaved by caspase 8.
We recently found that human TECs express TLR3,
MDA5, and RIG-I,24 suggesting that the cells are equipped to
induce antiviral defense mechanisms upon recognition of
viral dsRNA. Here, we aimed to study the function of viral
dsRNA sensors in the human renal tubular epithelium. We
observed that dsRNA receptor expression in kidney trans-
plant biopsies was enhanced during infection with CMV and
BKV and confirmed the expression of all three dsRNA
receptors in the renal tubuli. Upon activation, TLR3, MDA5,
and RIG-I enhanced the production of key pro-inflammatory
and antiviral cytokines in primary TECs. Notably, we
observed that dsRNA receptor ligands also enhanced the
expression of several apoptotic mediators. We explored the
mechanisms of apoptosis in TECs and found that dsRNA
receptor triggering did not reduce viability by itself but
sensitized the cells to CD95-mediated apoptosis.
RESULTS
Renal expression of TLR3, MDA5, and RIG-I is enhanced
during viral infection
To study the expression of TLR3, MDA5, and RIG-I in the
human kidney, we performed quantitative PCR analyses on
snap-frozen kidney transplant biopsies obtained during
active viral infection with CMV, EBV, and BKV. Transcript
levels were compared with levels in biopsies from patients
with stable renal function and normal histology (Figure 1a).
We found that transcription of TLR3, MDA5, and RIG-I was
significantly upregulated during infection with CMV and
BKV. EBV infection was not associated with an apparent
increase in dsRNA receptor mRNA. Immunohistochemical
stainings were performed to identify which cell types
expressed the dsRNA receptors (Figure 1b). TLR3 expression
was low in stable and EBV biopsies, but TLR3-positive tubuli
were present in all CMV biopsies and four of the seven BKV
biopsies (Figure 1b and Supplementary Figure S1A online).
MDA5 was broadly expressed in renal cells and infiltrating
immune cells, yet its expression was most prominent in the
proximal tubuli. We could not observe differences in MDA5
expression pattern and/or staining intensity between biopsies
obtained during viral infection and stable controls. In line
with the transcript levels, tubular RIG-I expression seemed
enhanced in biopsies obtained during infection with CMV
and BKV, as analyzed by semiquantitative scoring (Supple-
mentary Figure S1B online). Next to the tubular epithelium,
endothelial cells and graft-infiltrating leukocytes expressed
abundant levels of RIG-I. In summary, CMV and BKV
infection are associated with increased renal dsRNA receptor
expression, and TLR3, MDA5, and RIG-I are expressed by the
tubular epithelium during viral infection.
Viral dsRNA promotes the production of pro-inflammatory
and antiviral cytokines in primary TECs
dsRNA receptor triggering is known to activate IRF3/7 and
NF-kB, leading to the production of, respectively, antiviral
and pro-inflammatory cytokines.9,25,26 To address the ability
of dsRNA receptors to evoke antiviral immune responses in
TECs, we stimulated primary cells with known dsRNA
receptor ligands. Poly(I:C) is a synthetic dsRNA molecule
that activates both TLR3 and MDA5. Although administra-
tion of the ligand outside the cell predominantly triggers
TLR3, transfection is commonly used to activate MDA5.13,27
We used Fugene HD to deliver poly(I:C) or 50triphosphate
RNA (3pRNA), a specific RIG-I ligand, to the cytoplasm.
Activation of the dsRNA sensors dose dependently induced
transcription of IFN-b, the pro-inflammatory cytokines
tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6),
and the chemokine IFN-inducible protein 10 (Figure 2a and
Supplementary Figure S2A online). IFN-a mRNA was only
detectable after stimulation with high amounts of 3pRNA,
and culture supernatants contained no detectable amount of
IFN-a protein (ELISA data not shown). Notably, activation
of the cytoplasmic sensors MDA5 and RIG-I most promi-
nently induced IFN-b mRNA and protein expression,
whereas TLR3 was a more potent inducer of TNF-a
production (Figures 2b and c).
As a model for viral infection, we used influenza A, which
is known to activate TLR3 and RIG-I.28 Influenza enhanced
the transcription of TLR3, MDA5, IFN-b, and TNF-a
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(Supplementary Figure 2B and Figure 2D). Viable virus did
not promote the secretion of either IFN-b or TNF-a (Figure
2e and f), suggesting that influenza induces the expression of
viral proteins that interfere with proper translation and/or
secretion of host cytokines.8,29,30 We observed that the
induction of TLR3, MDA5, and IFN-b mRNA, but not that
of TNF-a transcripts, was abolished after heat inactivation of
the virus. TNF-a protein was abundantly produced in TECs
treated with heat-inactivated virus. These findings imply that
genomic RNA or protein present in heat-inactivated
influenza particles is recognized by TLR3 or other pattern
recognition receptors that mediate TNF-a expression. On the
other hand, heat-inactivated influenza did not induce
transcription and secretion of IFN-b. Thus, viral replication
seems to be required for triggering of the cytoplasmic dsRNA
sensors, which in our hands were the main inducers of IFN-b
in TECs. In summary, viral dsRNA receptors regulate
cytokine production in TECs. Antiviral cytokines were in
particular produced in response to dsRNA mimics delivered
to the cytoplasm, whereas extracellular dsRNA strongly
enhanced the expression of pro-inflammatory cytokines.
dsRNA receptor activation renders TECs sensitive to
CD95-mediated apoptosis
Several studies have shown that dsRNA receptor signaling can
induce death in a cell type–dependent manner. 13–18 We
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Figure 1 |Double-stranded RNA (dsRNA) receptor expression in the kidney is increased during viral infection. Expression of the
dsRNA receptors in kidney transplant biopsies obtained from patients with a stable renal function and normal histology (stable, n¼ 5) or
during infection with cytomegalovirus (CMV, n¼ 6), Epstein–Barr virus (EBV, n¼ 4), or BK virus (BKV, n¼ 7). (a) Transcript levels of Toll-like
receptor 3 (TLR3), melanoma differentiation–associated gene 5 (MDA5), and retinoic acid–inducible gene-I (RIG-I) determined by quantitative
PCR in snap-frozen biopsies (scatter, median). Expression levels in virus-infected biopsies were compared with stable biopsies
(Mann–Whitney U–tests, *Po0.05, **Po0.01). (b) Representative pictures of formalin-fixed, paraffin-embedded biopsies stained
immunohistochemically for TLR3, MDA5, or RIG-I.
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wondered whether dsRNA receptor triggering could promote
cell death in human TECs, and, if so, which apoptotic
pathways were involved. Annexin V and propidium iodide
staining showed that the great majority of TECs stimulated
with dsRNA analogs remained viable (Figure 3a). CD95
ligand–bearing cytotoxic lymphocytes can clear virus-infected
cells. We mimicked this immune cell interaction with an
agonistic antibody against CD95 (CH11). In agreement with
others,31,32 we found that TECs were resistant to CD95-
mediated apoptosis even at high concentrations of CH11
(4mg/ml; Figure 3a and Supplementary Figure S3A online).
Interestingly, dsRNA receptor activation induced CD95
expression (Figure 3b and data not shown) and rendered
TECs sensitive to CD95-mediated apoptosis in a dose-
dependent manner (Figure 3a, c and d). Extracellular
administration of 10 mg/ml poly(I:C) and intracellular
delivery of 0.1 mg/ml poly(I:C) or 3pRNA resulted in
comparable percentages of apoptotic TECs (Figure 3e);
therefore, we used these concentrations henceforth. TECs
infected with influenza underwent apoptosis after CD95
ligation as well (Figure 3f), demonstrating that virus can
activate a response similar to that of the tested dsRNA
receptor ligands. Activation of other TLRs that recognize viral
single-stranded RNA (TLR7), DNA (TLR9), or bacterial cell
wall (TLR2) or membrane (TLR4) compounds did not
render TECs sensitive to CD95-mediated apoptosis (Supple-
mentary Figure S3B online).
To analyze which signaling cascades, known to be induced
by dsRNA receptor triggering, are responsible for the
increased sensitivity to CD95-mediated apoptosis, we studied
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Figure 2 |Activation of viral double-stranded RNA (dsRNA) receptors promotes the production of pro-inflammatory and antiviral
cytokines in tubular epithelial cells (TECs). Primary TECs were stimulated for 16 h with poly(I:C) (pIC, 0.01–10 mg/ml), poly(I:C) and Fugene
(pICþ FG, 0.001–10 mg/ml), 50triphosphate RNA (3pRNA) and Fugene (3pRNAþ FG, 0.001–1 mg/ml), influenza A (Flu), heat-inactivated
influenza (30min at 56 1C), or kept unstimulated (no stim). (a, d) Transcript levels of interferon (IFN)-b and tumor necrosis factor (TNF)-a
determined by PCR. The PCR bands shown are representative of at least three experiments. Protein levels of IFN-b (b, e) and TNF-a (c, f)
analyzed by ELISA in culture supernatants of TECs stimulated for 24 h as described above (mean±s.e.m., n¼ 3).
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the involvement of several key mediators. In TECs, apoptosis
appeared to be NF-kB independent, as sensitivity to CD95-
mediated apoptosis was not induced by other NF-kB
activators, such as IL-1b and TLR2/4 ligands (Supplementary
Figure S3B online), and apoptosis induced by dsRNA and
CD95 was not affected by the NF-kB inhibitor Bay11-7082
(Supplementary Figure S4A online). Type I IFNs, which are
transcribed upon dsRNA receptor–induced IRF3/7 activation,
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Figure 3 |Triggering of double-stranded RNA (dsRNA) receptors renders tubular epithelial cells (TECs) sensitive to CD95-mediated
cell death. Primary TECs were stimulated with 0.01–10 mg/ml poly(I:C) (pIC), 0.01–10 mg/ml poly(I:C) plus Fugene (pICþ FG), or 0.01–0.1 mg/ml
50triphosphate RNA (3pRNA) plus Fugene (3pRNAþ FG) to activate Toll-like receptor 3, melanoma differentiation–associated gene 5,
and retinoic acid–inducible gene-I, or kept unstimulated (no stim). After 16 h, an agonistic IgM antibody against CD95 (CH11, 2 mg/ml) was
added for 24 h. The percentage of apoptotic TECs was determined by annexin V and propidium iodide staining and flow cytometry.
(a) Representative fluorescence-activated cell sorting plots of stimulated TECs. (b) CD95 expression on TECs stimulated with poly(I:C)
(0.1–100 mg/ml) depicted as mean fluorescent intensity (mean±s.e.m., n¼ 4). (c) Percentage of annexin Vþ TECs after stimulation with
increasing amounts of poly(I:C) (mean±s.e.m., n¼ 3). (d) Percentage of annexin Vþ TECs after stimulation with 3pRNA (mean, n¼ 2).
(e) Apoptosis in TECs after dsRNA receptor stimulation and CD95 ligation as described above (mean±s.e.m., n¼ 12). (f) Percentage of
annexin Vþ cells (mean±s.e.m., n¼ 3) after infection with influenza A (Flu) or heat-inactivated virus (30min at 56 1C) for 16 h, followed by
24 h incubation with CH11. (g) Percentage of Annexin Vþ TECs after stimulation with poly(I:C) (10mg/ml), interferon (IFN)-a (1000U/ml), or
IFN-b (1000U/ml) and anti-CD95 IgM (CH11) (mean±s.e.m., n¼ 6). Values measured after stimulation or infection were compared with
values found in resting TECs with unpaired t-tests. *Po0.05, **Po0.01, ***Po0.001.
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can induce or enhance apoptosis.12,33,34 IFN-a and IFN-b
slightly reduced TEC viability but did not render the cells
sensitive to CD95-mediated apoptosis, indicating that type I
IFNs were not the main mediators of cell death (Figure 3g).
In summary, dsRNA sensitizes TECs to CD95-mediated cell
death independently of type I IFNs and NF-kB.
The extrinsic and intrinsic apoptotic pathways are activated
in TECs upon stimulation of dsRNA receptors and CD95
Triggering of CD95 promotes auto-cleavage of pro-caspase 8,
leading to the activation of effector caspase 3, both directly
and via the mitochondrial route initiated by BID cleavage.22
To unravel the mechanism of CD95- and dsRNA-mediated
apoptosis, we analyzed the activation of the extrinsic and
intrinsic apoptosis pathways. CD95 stimulation alone did
induce cleavage of caspase 8, its inhibitor FLIP, and BID,
leading to some active caspase 3 (Figure 4a). By itself, dsRNA
did not promote caspase activation or cleavage of FLIP and
BID but did enhance expression of pro-caspase 8. Combined
activation of dsRNA receptor and CD95 facilitated the
generation of active caspase 3, both the 19-kDa form and the
17-kDa form. Apoptosis was blocked largely by the pan-
caspase inhibitor Q-VD-OPH and partially by the caspase 8
inhibitor Z-IETD-FMK, indicating involvement of caspase 8
(Figure 4b). Incomplete inhibition of cell death in the
presence of Z-IETD-FMK suggested involvement of the
mitochondrial pathway in dsRNA- and CD95-mediated
apoptosis. Indeed, the percentage of TECs with a reduced
DiOC6(3) staining, representing cells with a loss of
mitochondrial membrane potential, was increased after
triggering dsRNA receptors and CD95 (Figure 4c). It is
noteworthy that viral dsRNA did not render TECs sensitive to
apoptosis induced by two other death receptor ligands—
TNF-a and TRAIL—demonstrating that our findings are
specific for CD95 (Supplementary Figure S4B online). Thus,
CD95 and dsRNA trigger cell death, which is caspase
dependent and involves activation of both the extrinsic and
intrinsic pathways of apoptosis.
dsRNA receptors regulate the expression of pro- and
anti-apoptotic mediators
To address how dsRNA receptor activation sensitizes TECs to
CD95-mediated apoptosis, we analyzed the expression of
genes involved in cell death by multiplex ligation–dependent
probe amplification.35 In response to dsRNA, TECs rapidly
increased transcription of the pro-apoptotic proteins Noxa
and Puma and the inhibitors of apoptosis cIAP2 and NAIP
(Figure 5a and b). At the protein level, the induction of Noxa
and Puma coincided with increased expression levels of their
anti-apoptotic binding partner Mcl-1 (Figure 5c). Notably,
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the protein expression pattern observed after stimulation of
TLR3, MDA5, and RIG-I were largely comparable.
Next to Noxa and Puma, dsRNA receptor activation
induced the expression of several members of the IAP family
(Figure 5), which inhibit death receptor– and caspase-
mediated apoptosis.36 To study the influence of IAPs in
limiting CD95- and dsRNA-mediated apoptosis, we used a
Smac mimetic, compound A, which promotes proteasomal
degradation of IAPs (Figure 6a). Degradation of IAPs
rendered TECs sensitive to CD95-mediated apoptosis in a
dose-dependent manner (Figure 6b). Furthermore, we found
that TECs died after the addition of compound A and
dsRNA, demonstrating that dsRNA receptor could indeed
mediate apoptosis provided that IAPs were blocked. Combi-
nation of dsRNA receptor and CD95 activation and
compound A resulted in an even more pronounced cell
death (Figure 6c and Supplementary Figure S4C online). IAP
antagonists, such as compound A, can promote apoptosis via
NF-kB-stimulated production of TNF-a in sensitive tumor
cell lines.37 In TECs, TNF-a–mediated apoptosis did not have
a prominent role, as compound A did not enhance TNF-a
secretion (Supplementary Figure S4D online), and TNF-a by
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Figure 5 |Activation of double-stranded RNA (dsRNA) receptors promotes the expression of pro-apoptotic BH3-only and anti-
apoptotic IAP family members. Primary tubular epithelial cells (TECs) were stimulated with 10 mg/ml poly(I:C) (pIC) or 0.1 mg/ml poly(I:C)
and Fugene (pICþ FG) for 2 or 4 h, or kept unstimulated (no stim). Subsequently, mRNA expression levels of genes that mediate apoptosis
were determined by multiplex ligation–dependent probe amplification (MLPA). (a) Heat-map of fold change (log2) in gene expression
compared with unstimulated TECs. Each square represents a single measurement (n¼ 3). Genes that are upregulated are depicted in yellow,
and genes that are downregulated are depicted in blue. (b) Transcription levels of Bcl-XL, Mcl-1, Noxa, Puma, cIAP2, and XIAP measured by
MLPA are depicted as relative expression (arbitrary values, mean±s.e.m., n¼ 3). Values were compared with unstimulated cells with paired
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itself or in combination with dsRNA did not enhance
apoptosis (Supplementary Figure S4B online). Together, these
findings indicate that TECs are protected against various
apoptotic stimuli because of the expression of anti-apoptotic
proteins of the Bcl-2-like and IAP families.
DISCUSSION
Recently, we found that human renal TECs express the
dsRNA receptors TLR3, MDA5, and RIG-I.24 We here
demonstrate that the expression of these receptors in human
kidney transplants is enhanced during viral infection. Each
receptor had a unique distribution, yet all could be detected
in the renal tubuli. In agreement, we found that in primary
TECs activation of TLR3, MDA5, and RIG-I induced the
production of antiviral and pro-inflammatory cytokines.
Furthermore, we observed that viral dsRNA induced a
pro-apoptotic program that sensitized TECs to CD95-
mediated apoptosis. Both the extrinsic and intrinsic apopto-
tic pathways were activated in response to dsRNA and CD95
ligation. In a broader context, this suggests that upon
encounter of viral dsRNA or dsRNA from any other source
TECs become susceptible to CD95-mediated cell death.
Several findings suggest that dsRNA receptors are involved
in the recognition of DNA viruses that may reactivate in
immunosuppressed kidney transplant recipients. CMV has
been shown to activate TLR3 in THP-1 cells38 and to induce a
type I IFN response independent of TLR3 in dendritic cells.39
EBV-encoded small RNAs are known ligands for TLR3
and RIG-I.40,41 We observed that tubular dsRNA receptor
expression was hardly increased during EBV infection. This
might be due to the small sample size, but more likely reflects
the low percentage of tubuli infected by EBV. EBV
predominantly targets B cells,42 whereas CMV is promiscu-
ous,43,44 and BKV infects epithelial cells of the urogenital
tract.5 Furthermore, EBV only rarely causes tubulitis and/or
tubular injury in contrast to the other viruses.45,46
RIG-I was highly expressed in graft-infiltrating lympho-
cytes and endothelial cells, which can be infected by CMV.43
In glomerular endothelial cells, dsRNA-induced antiviral
responses are mediated by RIG-I.47 Endothelial expression
of the cytoplasmic sensor is induced by poly(I:C) and
IFN-g,48,49 a cytokine abundantly produced by CMV-specific
T cells.50 Together, these findings suggest that endothelial
RIG-I expression found in renal biopsies may result from
viral infection.
A recent study by Ribeiro and co-workers showed that
BKV infection promoted the transcription of TLR3, RIG-I,
and inflammatory mediators in renal collecting duct cells,51
suggesting that the virus can trigger one or more dsRNA
receptors as well. Furthermore, the authors observed
enhanced transcription of TLR3, but not of RIG-I, in
biopsies with BKV-associated nephropathy as compared with
donor biopsies. Our study confirms and extends these
observations by demonstrating that TLR3, MDA5, and
RIG-I mRNA levels were increased during BKV and CMV
infection. We used biopsies obtained from stable transplant
patients without rejection or infection as a control, which
could explain the discrepancy in RIG-I transcription. BKV-
associated nephropathy and acute cellular rejection are
remarkably similar, based on immunohistological analysis
and gene expression profile.52 Indeed, TLR3 and RIG-I
transcription in the kidney seems enhanced during acute
rejection as well,51,53 suggesting that dsRNA receptor
expression is a general characteristic of renal inflammation.
Microarray analyses showed that BKV infection increases
cell cycle and apoptosis gene expression in TECs and
endothelial cells.54,55 Key viral defense genes were, however,
not induced by BKV, which might be the result of
immunosuppressive mechanisms developed by the virus. In
line with this hypothesis, BKV-induced transcription of
IL-6 and IL-8 in collecting duct cells occurred only within the
first 6 h.51
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Figure 6 | IAPs control apoptosis induced by CD95 or double-
stranded RNA (dsRNA) receptor activation in tubular
epithelial cells (TECs). (a) Expression of cIAP1 in TECs stimulated
with compound A (5–500 nmol/l, 30–120min) analyzed by western
blotting. (b) TECs incubated with compound A (30min) were
stimulated with anti-CD95 IgM (CH11, 2 mg/ml, 24 h), poly(I:C) (pIC,
40 h), poly(I:C) with Fugene (pICþ FG, 40 h), or kept unstimulated
(no stim). Apoptosis was analyzed by flow cytometry; the bars
represent the percentage of annexin Vþ TECs (mean, n¼ 2). (c)
Fluorescence-activated cell sorting plots of TECs stimulated as
described above stained with annexin V and propidium iodide,
representative of two experiments.
Kidney International (2012) 82, 664–675 671
KM Heutinck et al.: Versatility of viral dsRNA sensors in renal tubuli o r i g ina l a r t i c l e
It is increasingly recognized that dsRNA receptor activa-
tion can promote apoptosis. First of all, activation of MDA5
and RIG-I has been shown to trigger the intrinsic apoptotic
pathway via enhanced Noxa expression in various cancer
cells.13,14,56 Second, RIG-I stimulation has been demon-
strated to promote direct interaction of IRF-3 with Bax
followed by loss of mitochondrial membrane potential.15 In
mesangial cells and some myeloma cell lines, apoptosis is
mediated by type I IFNs, which are produced in response to
poly(I:C).57,58 Finally, TLR3 and its adaptor TRIF directly
induced activation of caspase 8 in keratinocytes.18 Here, we
demonstrate for the first time a role of dsRNA receptors in
the induction of apoptosis in the kidney and provide some
insights into the mechanisms involved. Figure 7 schematically
depicts the influence of dsRNA receptor triggering on the
extrinsic and intrinsic pathways of apoptosis in TECs.
In agreement with previous studies, we found that dsRNA
receptor activation induced expression of the pro-apoptotic
BH3-only proteins Noxa and Puma.13,14,18 Noxa and Puma
inhibit the anti-apoptotic Bcl-2-like proteins. Puma is a
promiscuous inhibitor, whereas Noxa specifically interacts
with Mcl-1, A1, and probably Bcl-XL.59–61 In primary TECs,
Noxa and Puma induction appeared to coincide with an
increased amount of their antagonist Mcl-1. Furthermore,
Bcl-XL, another Bcl-2-like protein that can protect against
MDA5- or RIG-I-mediated apoptosis,13 was highly expressed
in resting and stimulated TECs. Unfortunately, we could not
address the exact contribution of dsRNA-induced Noxa and
Puma to apoptosis, as small interfering and short hairpin
RNA molecules seemed to enhance apoptosis in primary
TECs (data not shown).
TECs constitutively expressed high levels of XIAP, a
known inhibitor of the apoptosome.36 dsRNA induced the
expression of cellular IAPs, which can inhibit death
receptor–mediated apoptosis but also have an important role
in cell signaling.36,62 We found that dsRNA did not promote
activation of caspase 8 and/or caspase 3. However, in the
absence of IAPs, poly(I:C) did induce cell death in a caspase
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8–dependent manner (Supplementary Figure S4C online).
Thus, it seems likely that TECs are protected against dsRNA
receptor–mediated apoptosis due to expression of Bcl-2-like
and IAP family members.
It is known that despite constitutive CD95 expression
TECs are resistant to CD95-mediated apoptosis.31,32 In
agreement herewith, we found that CD95 activation by itself
did not result in cell death. CD95 ligation did induce the
cleavage of pro-caspase 8, its inhibitor FLIP, and BID,
demonstrating that TECs are so-called type II cells in which
caspase 3 is not directly cleaved by caspase 8 in response to
CD95 ligation. Type II cells express high levels of XIAP and
require amplification of the apoptotic signal via the intrinsic
apoptotic pathway.63 Indeed, we found that CD95 triggering
induced apoptosis in the presence of an IAP antagonist,
which was almost completely caspase 8–dependent. This sug-
gests that IAP inhibitors can turn type II cells, such as TECs,
into type I cells. Moreover, we found that dsRNA receptor
activation rendered TECs sensitive to CD95-mediated
apoptosis. In line with these findings, other studies have
demonstrated that human and murine TECs require a second
signal such as inflammatory cytokines to become sensitive to
apoptotic stimuli, such as CD95 ligand and TRAIL.31,64–66 It
is noteworthy that the activation of dsRNA receptors did not
enhance sensitivity to apoptosis induced by the death receptor
ligands TNF-a and TRAIL, suggesting that viral dsRNA
specifically sensitizes TECs for CD95-mediated apoptosis.
In summary, our data demonstrate that TLR3, MDA5, and
RIG-I contribute to antiviral immune responses in the
human kidney and suggest that the dsRNA receptors have a
role in the recognition of CMV and BKV, latent viruses that
regularly reactivate in kidney transplant recipients. Further-
more, we show that dsRNA receptor activation induces a pro-
apoptotic program, which sensitizes TECs to CD95-mediated
apoptosis. The net balance in expression levels of pro- and
anti-apoptotic mediators such as Noxa, Puma, Bcl-2-like
family members, and IAPs appears to determine the
sensitivity of TECs to various apoptotic stimuli, thereby
defining whether infected cells are sensitive to CD95-
mediated cell death leading to viral clearance or whether
they survive allowing viral persistence.
MATERIALS AND METHODS
Kidney transplant patients
We included 22 kidney transplant biopsies performed by protocol or
upon clinical indication. Viral infection was diagnosed by positive
peripheral blood PCR, specific antibody conversion, and/or
immunohistochemistry. Supplementary Table S1 online depicts the
patient characteristics. Written informed consent was obtained from
all study patients, and the study was approved by the Institutional
Ethics Committee of the Academic Medical Center.
mRNA measurements
dsRNA receptor expression, determined by quantitative PCR in
mRNA isolated from snap-frozen renal biopsies, was normalized to
a control sample and glyceraldehyde 3-phosphate dehydrogenase.
Cytokine expression in stimulated TECs was determined by
semiquantitative PCR. Primer characteristics are depicted in
Supplementary Table S2 online.
Immunohistochemistry
Immunohistochemical stainings were performed on formalin-fixed
paraffin-embedded tissue slides with a monoclonal mouse IgG1
antibody against TLR3 (5 mg/ml, clone 40C1285.6; Abnova,
Heidelberg, Germany), a polyclonal goat antibody against MDA5
(2.5 mg/ml; Imgenex, San Diego, CA), and a monoclonal mouse
IgG1 antibody against RIG-I (2.5 mg/ml, clone Alme-1; Axxora,
San Diego, CA).
Culture and stimulation of primary TECs
Primary TECs were isolated and cultured according to the method
described previously 67 and stimulated with IFN-a2a and IFN-b1a
(100–1000 U/ml; PBL InterferonSource, Piscataway, NJ), polyino-
sinic-polycytidylic acid (poly(I:C), 0.01–10 mg/ml; Sigma-Aldrich,
Zwijndrecht, The Netherlands), 3pRNA (10–1000 ng/ml), a kind gift
from Professor G Hartmann and Dr M Schlee (University Hospital
Bonn, Germany), combined with Fugene HD (Roche, Mannheim,
Germany) and/ or monoclonal IgM antibody (CH11) against CD95
(2mg/ml; Beckman Coulter, Woerden, The Netherlands). The
inhibitors used were chloroquine (10–100 mmol/l; Sigma-Aldrich),
Z-IETD-FMK (20 mmol/l; Sigma-Aldrich), Q-VD-OPH (20mmol/l;
R&D systems, Minneapolis, MN), and compound A, kindly
provided by Tetralogic Pharmaceuticals (Malvern, PA). Influenza
A (strain A/PR/8/34) was a kind gift from Dr G Rimmelzwaan
(Erasmus Medical Center Rotterdam, The Netherlands).
ELISA
The human TNF-a ELISA kit (Sanquin, Amsterdam, The Netherlands)
and human IFN-b ELISA kit (Alexis Biochemicals, San Diego, CA)
were used according to the instructions of the manufacturer.
Flow cytometry
TECs were stained with Annexin V (FITC conjugated; IQ products,
Groningen, The Netherlands), propidium iodide (Sigma-Aldrich),
FITC-labeled monoclonal IgG1 antibody against CD95 and isotype
control (BD Biosciences, San Jose, CA), or 3,30-dihexyloxacarbo-
cyanine iodide (DiOC6(3); Invitrogen, Breda, The Netherlands) and
analyzed on a flow cytometer (FACSCalibur; BD Biosciences).
Western blot analysis
Cells were lysed in 1% Triton-X supplemented with protease
inhibitor cocktail (Roche). Proteins were separated by SDS-
polyacrylamide gel electrophoresis and transferred to a nitrocellu-
lose membrane. Supplementary Table S3 online depicts the primary
antibodies used. Immunoreactive proteins were visualized with the
Odyssey Infrared Imaging System (LI-COR Biotechnology, Bad
Homburg, Germany).
Multiplex ligation–dependent probe amplification
The SALSA MLPA kit R011 Apoptosis (MRC-Holland, Amsterdam,
The Netherlands) was used according to the manufacturer’s
protocol. Relative gene expression was defined as the ratio of each
measured peak area to the combined peak area of all genes. The fold
change (2-log) compared with unstimulated TECs was calculated and
depicted as heat-map using the MultiExperiment Viewer software
(version v4.6.1; Dana-Farber Cancer Institute, Boston, MA).
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Statistical analysis
Statistical analyses were performed in Graph Pad Prism (version 5;
GraphPad software, La Jolla, CA). dsRNA receptor transcript levels
in biopsies were compared with Mann–Whitney U-tests. Individual
values, corresponding to measurements in TEC cultures derived
from different patients, were compared with paired Student’s t-tests.
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